CSIMarket
 


Nautilus Biotechnology Inc   (NAUT)
Other Ticker:  
 
 

NAUT's Operating Income Growth by Quarter and Year

Nautilus Biotechnology Inc 's Operating Income results by quarter and year




NAUT Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -20.00 -16.30 25.27 0.00
III Quarter September -19.08 -15.82 -14.57 0.00
II Quarter June -19.02 -15.47 -10.70 0.00
I Quarter March -18.06 -16.02 0.00 0.00
FY   -76.16 -63.61 0.00 0.00



NAUT Operating Income fourth quarter 2023 Y/Y Growth Comment
Nautilus Biotechnology Inc in the fourth quarter 2023 recorded Operating Loss of $ -20.00 millions.

According to the results reported in the fourth quarter 2023, Nautilus Biotechnology Inc achieved the best Operating Income growth in Laboratory Analytical Instruments industry. While Nautilus Biotechnology Inc ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


NAUT Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Nautilus Biotechnology Inc 's fourth quarter 2023 Operating Income $ -20.00 millions NAUT's Income Statement
Nautilus Biotechnology Inc 's fourth quarter 2022 Operating Income $ -16.30 millions Quarterly NAUT's Income Statement
New: More NAUT's historic Operating Income Growth >>


NAUT Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nautilus Biotechnology Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NAUT's IV. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -20.00 millions by Nautilus Biotechnology Inc look even more unfavourable if you take a look at -19.08 millions Operating Loss a quarter before.

Within Laboratory Analytical Instruments industry Nautilus Biotechnology Inc achieved highest sequential Operating Income growth. While Nautilus Biotechnology Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NAUT's IV. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -20.00 millions by Nautilus Biotechnology Inc look even less good if you take a look at -19.08 millions Operating Loss a quarter before.

Within Laboratory Analytical Instruments industry Nautilus Biotechnology Inc achieved highest sequential Operating Income growth. While Nautilus Biotechnology Inc 's Operating Income growth quarter on quarter, overall rank is .


Nautilus Biotechnology Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -76.15 $ -72.46 $ -69.20 $ -65.66 $ -63.62
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Nautilus Biotechnology Inc ' has realized cumulative trailing twelve months Operating Loss of $ -76 millions in the Dec 31 2023 period.
The situation is worsening as the cumulative Operating Loss is inflating from $ -72.46 millions in the twelve months ending a quarter before and $ -22.049 millions from the TTM period ending Dec 31 2022 Ian Walsh wrote.

Nautilus Biotechnology Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Nautilus Biotechnology Inc ' has realized cumulative trailing twelve months Operating Loss of $ -76 millions in the Dec 31 2023 period.
The situation is detiriorating as the cumulative Operating Loss is becoming larger from $ -72.46 millions in TTM ending quarter Sep 30 2023 and $ -22.049 millions from the TTM period ending Dec 31 2022.

Nautilus Biotechnology Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Laboratory Analytical Instruments Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
NAUT's Operating Income Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for NAUT's Competitors
Operating Income Growth for Nautilus Biotechnology Inc 's Suppliers
Operating Income Growth for NAUT's Customers

You may also want to know
NAUT's Annual Growth Rates NAUT's Profitability Ratios NAUT's Asset Turnover Ratio NAUT's Dividend Growth
NAUT's Roe NAUT's Valuation Ratios NAUT's Financial Strength Ratios NAUT's Dividend Payout Ratio
NAUT's Roa NAUT's Inventory Turnover Ratio NAUT's Growth Rates NAUT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Powerup Acquisition Corp 39.00%$ 38.999 millions
Tenet Healthcare Corp37.13%$ 37.127 millions
Chemed Corporation36.97%$ 36.971 millions
Abbott Laboratories36.50%$ 36.503 millions
Nature s Sunshine Products inc 36.49%$ 36.490 millions
Halozyme Therapeutics Inc 35.60%$ 35.601 millions
Catalyst Pharmaceuticals Inc 35.36%$ 35.359 millions
Iqvia Holdings Inc 32.19%$ 32.190 millions
Select Medical Holdings Corp31.53%$ 31.531 millions
Alpha Pro Tech Ltd 27.93%$ 27.931 millions
West Pharmaceutical Services Inc 24.06%$ 24.056 millions
Option Care Health Inc 24.00%$ 23.997 millions
Intuitive Surgical Inc 20.86%$ 20.859 millions
Bionomics Limited20.74%$ 20.739 millions
Icon Plc20.23%$ 20.235 millions
The Pennant Group Inc 18.53%$ 18.531 millions
Integer Holdings Corporation18.03%$ 18.033 millions
Ufp Technologies Inc 17.10%$ 17.102 millions
Encompass Health Corporation16.59%$ 16.587 millions
Fonar Corporation15.43%$ 15.430 millions
Medpace Holdings Inc 14.25%$ 14.247 millions
Steris Plc13.29%$ 13.288 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com